万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://academic.oup.com/intimm
3、投稿网址：http://mc.manuscriptcentral.com/intimm
4、官网邮箱：ii.editorialoffice@oup.com（编辑部）
5、官网电话：+81 6 6816 3387
6、期刊刊期：月刊，一年出版12期。
2021年8月17日星期二
投稿须知【官网信息】
International Immunology
Instructions to Authors
Please note that the journal has been ONLINE ONLY since the 2018 January issue, when we ceased publication of the print issue altogether. There are now no supplementary charges for colour printing and we do not offer the option to purchase offprints of papers published in the journal. All authors continue to receive a free access link to their paper upon publication.
Open Access
International Immunology offers the option of publishing under either a standard licence or an open access licence. Please note that some funders require open access publication as a condition of funding. If you are unsure whether you are required to publish open access, please do clarify any such requirements with your funder or institution.
Should you wish to publish your article open access, you should select your choice of open access licence in our online system after your article has been accepted for publication. You will need to pay an open access charge to publish under an open access licence.
Details of the open access licences and open access charges.
OUP has a growing number of Read and Publish agreements with institutions and consortia which provide funding for open access publishing. This means authors from participating institutions can publish open access, and the institution may pay the charge. Find out if your institution is participating.
Please note that you may be eligible for a discount to the open access charge based on society membership. Authors may be asked to prove eligibility for the member discount.
General Information
International Immunology publishes basic research and clinical studies from all areas of immunology and includes research conducted in laboratories throughout the world.
Areas that are covered include allergy, autoimmunity, chemical and structural immunology, clinical immunology, cytokines and chemokines, development of lymphoid organs, immunological methods, infection immunity, innate immunity and inflammation, lymphocyte and repertoire development, lymphocyte signalling, mucosal immunity, phylogeny of the immune system, regulation of immune responses, systems immunology, translational immunology, tumour immunity, and transplantation. Articles for the “immunological methods” category should include data comparing the new method with previous methods. Studies from related biological disciplines that have direct implications for immunology are also considered.
The journal publishes only new material. Submission of a paper will be taken to imply that it reports unpublished work and that the work is not being considered for publication elsewhere. Relevant permission must be obtained for any 'personal communication' of unpublished work that is cited in this manuscript. Submission will, furthermore, be taken to imply that, if the paper is published, hybridomas, cell lines, gene clones, rDNA constructs, etc., used in the studies described therein will be made available to interested investigators for their use only in their own research.
International Immunology takes publication ethics very seriously. If misconduct is found or suspected after the manuscript is published, the journal will investigate the matter and this may result in the article subsequently being retracted.
There is no absolute restriction on length of manuscripts. International Immunology does not have page charges or (from January 2018) colour-figure charges; there are also no article-processing fees. Following publication, the corresponding author will be sent URL links providing free online access to their paper.
Types of Papers Accepted
The main part of each issue is devoted to original research papers, which should describe significant and original observations, especially those that provide mechanistic biological insights into the workings of the immune system.
We will consider clinical studies that provide novel insights into immunological diseases or progress in therapeutic manipulation of human immune responses. We will not, however, consider Case Reports.
We also include Short Communications, which should describe solid but straightforward findings that may provoke further more-comprehensive studies. These can have up to four figures and the "Results" and "Discussion" sections should be combined.
The journal also publishes Letters to the Editor-in-Chief and Author's Replies. The Letter should discuss an article recently published in International Immunology. Letters should discuss the data reported in the published research paper (i.e. methods and results), not the implications that come from them. The maximum word-count for Letters is 450 and there can be up to five references, including reference to the original article; figures can be included as supplementary data. The Letter will be sent to the authors of the original article, who can publish a Reply. If you are interested in commenting on a published paper in this way, please e-mail the Editor-in-Chief (ii.editorialoffice@oup.com).
……
更多详情：
https://academic.oup.com/intimm/pages/Instructions_To_Authors
